<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dalla Barba F</submitter><funding>University of Ferrara research grants</funding><funding>Association Françoise contre les Myopathies</funding><funding>Muscular Dystrophy Association</funding><pagination>12707</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10454440</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(16)</volume><pubmed_abstract>Sarcoglycanopathies, also known as limb girdle muscular dystrophy 3-6, are rare muscular dystrophies characterized, although heterogeneous, by high disability, with patients often wheelchair-bound by late adolescence and frequently developing respiratory and cardiac problems. These diseases are currently incurable, emphasizing the importance of effective treatment strategies and the necessity of animal models for drug screening and therapeutic verification. Using the CRISPR/Cas9 genome editing technique, we generated and characterized δ-sarcoglycan and β-sarcoglycan knockout zebrafish lines, which presented a progressive disease phenotype that worsened from a mild larval stage to distinct myopathic features in adulthood. By subjecting the knockout larvae to a viscous swimming medium, we we</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Modeling Sarcoglycanopathy in &lt;i>Danio rerio&lt;/i>.</pubmed_title><pmcid>PMC10454440</pmcid><funding_grant_id>18620</funding_grant_id><funding_grant_id>577888: doi.org/10.55762/pc.gr.81540</funding_grant_id><funding_grant_id>23765</funding_grant_id><funding_grant_id>FAR2022</funding_grant_id><pubmed_authors>Scano M</pubmed_authors><pubmed_authors>Sandona D</pubmed_authors><pubmed_authors>Dalla Barba F</pubmed_authors><pubmed_authors>Lucon-Xiccato T</pubmed_authors><pubmed_authors>Argenton F</pubmed_authors><pubmed_authors>Mouhib L</pubmed_authors><pubmed_authors>Sacchetto R</pubmed_authors><pubmed_authors>Soardi M</pubmed_authors><pubmed_authors>Bertolucci C</pubmed_authors><pubmed_authors>Benetollo A</pubmed_authors><pubmed_authors>Richard I</pubmed_authors><pubmed_authors>Risato G</pubmed_authors><pubmed_authors>Akyurek EE</pubmed_authors><pubmed_authors>Carotti M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modeling Sarcoglycanopathy in &lt;i>Danio rerio&lt;/i>.</name><description>Sarcoglycanopathies, also known as limb girdle muscular dystrophy 3-6, are rare muscular dystrophies characterized, although heterogeneous, by high disability, with patients often wheelchair-bound by late adolescence and frequently developing respiratory and cardiac problems. These diseases are currently incurable, emphasizing the importance of effective treatment strategies and the necessity of animal models for drug screening and therapeutic verification. Using the CRISPR/Cas9 genome editing technique, we generated and characterized δ-sarcoglycan and β-sarcoglycan knockout zebrafish lines, which presented a progressive disease phenotype that worsened from a mild larval stage to distinct myopathic features in adulthood. By subjecting the knockout larvae to a viscous swimming medium, we we</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-07-10T03:08:15.648Z</modification><creation>2025-04-04T07:13:43.771Z</creation></dates><accession>S-EPMC10454440</accession><cross_references><pubmed>37628888</pubmed><doi>10.3390/ijms241612707</doi></cross_references></HashMap>